COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes

Journal of Molecular Biology

Volumn 294, Issue 2, 1999, Pages 443-456

  Flavigny, Jeanne ^c   Souchet, Michel ^b   Sébillon, Pascale ^c   Berrebi Bertrand, Isabelle ^b   Hainque, Bernard ^c   Mallet, Alain ^a   Bril, Antoine ^b   Schwartz, Ketty ^c   Carrier, Lucie ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SmithKline Beecham Laboratoires P   (France)

^c NONE

Author keywords

Cardiomyocytes; Familial hypertrophic cardiomyopathy; Mutations; Myosin binding protein; Protein sequence analysis

Indexed keywords

MUTANT PROTEIN; MYOMESIN; MYOSIN; MYOSIN BINDING PROTEIN C; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FETUS; HEART MUSCLE CELL; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SARCOMERE; SEQUENCE HOMOLOGY;

ANIMALIA;

EID: 0033607481     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3276     Document Type: Article

References (57)

1. Alyonycheva T. N., Mikawa T., Reinach F. C., Fischman D. A. Isoform-specific interaction of the myosin-binding proteins (MyBPs) with skeletal and cardiac myosin is a property of the C-terminal immunoglobulin domain. J. Biol. Chem. 272:1997;20866-20872.
2. Auerbach D., Bantle S., Keller S., Hinderling V., Leu M., Ehler E., Perriard J. C. Different domains of the M-band protein myomesin are involved in myosin binding and M-band targeting. Mol. Biol. Cell. 10:1999;1297-1308.
3. Bantle S., Keller S., Haussmann I., Auerbach D., Perriard E., Mühlebach S., Perriard J. C. Tissue-specific isoforms of chicken mymesin are generated by alternative splicing. J. Biol. Chem. 271:1996;19042-19052.
4. Becker K. D., Gottshall K. R., Hickey R., Perriard J. C., Chien K. R. Point mutations in human β cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly. J. Cell. Biol. 137:1997;131-140.
5. Bonne G., Carrier L., Bercovici J., Cruaud C., Richard P., Hainque B., Gautel M., Labeit S., James M., Beckmann J. S., Weissenbach J., Vosberg H. P., Fiszman M., Komajda M., Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genet. 11:1995;438-440.
6. Bonne G., Carrier L., Richard P., Hainque B., Schwartz K. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ. Res. 83:1998;579-593.
7. Bottinelli R., Coviello D. A., Redwood C. S., Pellegrino M. A., Maron B. J., Spirito P., Watkins H., Reggiani C. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ. Res. 82:1998;106-115.
8. Callebaut I., Labesse G., Durand P., Poupon A., Canard L., Chomilier J., Henrissat B., Mornon J. P. Deciphering protein sequence information through hydrophobic cluster analysis (HCA): current status and perspectives. Cell. Mol. Life Sci. 53:1997;621-645.
9. Carrier L., Bonne G., Bährend E., Yu B., Richard P., Niel F., Hainque B., Cruaud C., Gary F., Labeit S., Bouhour J. B., Dubourg O., Desnos M., Hagège A. A., Trent R. J., Komajda M., Schwartz K. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ. Res. 80:1997;427-434.
10. Charron P., Dubourg O., Desnos M., Bennaceur M., Carrier L., Camproux A. C., Isnard R., Hagège A., Langlard J. M., Bonne G., Richard P., Hainque B., Bouhour J. B., Schwartz K., Komajda M. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to cardiac myosin binding protein C gene. Circulation. 97:1998;2230-2236.
11. Craig R., Offer G. The location of C-protein in rabbit skeletal muscle. Proc. Roy. Soc. ser. B. 192:1976;451-461.
12. Cuda G., Fananapazir L., Epstein N. D., Sellers J. R. The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. J. Muscle Res. Cell Motil. 18:1997;275-283.
13. Dennis J. E., Shimizu F., Reinach F. C., Fischman D. A. Localization of C-protein isoforms in chicken skeletal muscle: ultrastructural detection using monoclonal antibodies. J. Cell Biol. 98:1984;1514-1522.
14. Einheber S., Fischman D. A. Isolation and characterization of a cDNA clone encoding avian skeletal muscle C-protein: an intracellular member of the immunoglobulin superfamily. Proc. Natl Acad. Sci. USA. 87:1990;2157-2161.
15. Evans G. I., Lewis G. K., Ramsay G., Bishop V. M. Isolation of monoclonal antibodies specific for c-myc proto-oncogene product. Mol. Cell. Biol. 5:1985;3610-3616.
16. Fougerousse F., Delezoide A. L., Fiszman M. Y., Schwartz K., Beckmann J. S., Carrier L. Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development. Circ. Res. 82:1998;130-133.
17. Freiburg A., Gautel M. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur. J. Biochem. 235:1996;317-326.
18. Fürst D. O., Vinkemeyer U., Weber K. Mammalian skeletal muscle C-protein: purification from bovine muscle, binding to titin and the characterization of a full-length cDNA. J. Cell Sci. 102:1992;769-778.
19. Gautel M., Zuffardi O., Freiburg A., Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein C: a modulator of cardiac contraction? EMBO J. 14:1995;1952-1960.
20. Gautel M., Fürst D. O., Cocco A., Schiaffino S. Isoform transitions of the myosin-binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle. Circ. Res. 82:1998;124-129.
21. Geisterfer-Lowrance A. A. T., Christe M., Conner D. A., Ingwall J. S., Schoen F. J., Seidman C. E., Seidman J. G. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:1996;731-734.
22. Gruen M., Gautel M. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin binding protein-C. J. Mol. Biol. 286:1999;933-949.
23. Halaby D. M., Mornon J. P. E. The immunoglobulin superfamily: an insight on its tissular, species, and functional diversity. J. Mol. Evol. 46:1998;389-400.
24. Heimer G., Taylor C. Improved mountant for immunofluorescence preparations. J. Clin. Pathol. 27:1974;254-256.
25. 2+ activation. J. Physiol. 439:1991;701-715.
26. Koretz J. F., Coluccio L. M., Bertasso A. M. The aggregation characteristics of column-purified rabbit skeletal myosin in the presence and absence of C-protein at pH 7.0. Biophys. J. 37:1982;433-440.
27. Koretz R. Effects of C-protein on synthetic myosin filament structure. Biophys. J. 27:1979;433-446.
28. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
29. Maron B. J., Bonow R. O., Cannon R. O., Leon M. B., Epstein S. E. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. New Engl. J. Med. 316:1987a;780-789.
30. Maron B. J., Bonow R. O., Cannon R. O., Leon M. B., Epstein S. E. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. New Engl. J. Med. 316:1987b;844-852.
31. Mogensen J., Klausen I. C., Pedersen A. K., Egeblad H., Bross P., Kruse T. A., Gregersen N., Hansen P. S., Baandrup U., Borglum A. D. α-Cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J. Clin. Invest. 103:1999;R39-R43.
32. Moos C., Feng I. N. M. Effect of C-protein on actomyosin ATPase. Biochim. Biophys. Acta. 632:1980;141-149.
33. Moos C., Mason C. M., Besterman J. M., Feng I. N. M., Dubin J. H. The binding of skeletal muscle C-protein to F-actin, and its relation to the interaction of actin with myosin subfragment-1. J. Mol. Biol. 124:1978;571-586.
34. Nave R., Furst D. O., Weber K. Visualization of the polarity of isolated titin molecules: a single globular head on a long thin rod as the M band anchoring domain? J. Cell Biol. 109:1989;2177-2187.
35. Niimura H., Bachinski L. L., Sangwatanaroj S., Watkins H., Chudley A. E., McKenna W., Kristinsson A., Roberts R., Sole M., Maron B. J., Seidman J. G., Seidman C. E. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. New Engl. J. Med. 338:1998;1248-1257.
36. Obermann W., Plessmann U., Weber K., Furst D. Purification and biochemical characterization of myomesin, a myosin-binding and titin-binding protein, from bovine skeletal muscle. Eur. J. Biochem. 233:1995;110-115.
37. Obermann W. M. J., Gautel M., Weber K., Fürst D. O. Molecular structure of the sarcomeric M band: mapping of titin and myosin binding domains in myomesin and the identification of a potential phosphorylation site in myomesin. EMBO J. 16:1997;211-220.
38. Obermann W. M. J., van der Ven P. F. M., Steiner F., Weber K., Fürst D. O. Mapping of a myosin-binding domain and a regulatory phosphorylation site in M-protein, a structural protein of the sarcomeric M band. Mol. Biol. Cell. 9:1998;829-840.
39. Okagaki T., Weber F. E., Fischman D. A., Vaughan K. T., Mikawa T., Reinach F. C. The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J. Cell Biol. 123:1993;619-626.
40. Pepe F., Drucker B. The myosin filament. III. C-protein. J. Mol. Biol. 99:1975;609-617.
41. Price M. G., Gomer R. H. Skelemin, a cytoskeletal M-disc periphery protein, contains motifs of adhesion/recognition and intermediate filament proteins. J. Biol. Chem. 268:1993;21800-21810.
42. Rottbauer W., Gautel M., Zehelein J., Labeit S., Franz W. M., Fischer C., Vollrath B., Mall G., Dietz R., Kübler W., Katus H. A. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J. Clin. Invest. 100:1997;475-482.
43. Rust E. M., Albayya F. P., Metzger J. M. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins. J. Clin. Invest. 103:1999;1459-1467.
44. Sanger F., Nicklen S., Coulson A. DNA sequencing with chain terminating inhibitors. Proc. Natl Acad. Sci. USA. 74:1977;5460-5467.
45. Satoh M., Takahashi M., Sakamoto T., Hiroe M., Marumo F., Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem. Biophys. Res. Commun. 262:1999;411-417.
46. Schiaffino S., Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol. Rev. 76:1996;371-423.
47. Seiler S. H., Fischman D. A., Leinwand L. A. Modulation of myosin filament organization by C-protein family members. Mol. Biol. Cell. 7:1996;113-127.
48. Smith D. K., Xue H. Sequence profiles of immunoglobulin and immunoglobulin-like domains. J. Mol. Biol. 274:1997;530-545.
49. Starr R., Offer G. The interaction of C-protein with heavy meromyosin and subfragment-2. Biochem. J. 171:1978;813-816.
50. Sweeney H. L., Feng H. S., Yang Z., Watkins H. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc. Natl Acad. Sci. USA. 95:1998;14406-14410.
51. Tardiff J. C., Factor S. M., Tompkins B. D., Hewett T. E., Palmer B. M., Moore R. L., Schwartz S., Robbins J., Leinwand L. A. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J. Clin. Invest. 101:1998;2800-2811.
52. Watkins H., Seidman C. E., Seidman J. G., Feng H. S., Sweeney H. L. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. J. Clin. Invest. 98:1996;2456-2461.
53. Weisberg A., Winegrad S. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc. Natl Acad. Sci. USA. 93:1996;8999-9003.
54. Weisberg A., Winegrad S. Relation between crossbridges structure and actomyosin ATPase activity in rat heart. Circ. Res. 83:1998;60-72.
55. Woodcock S., Mornon J., Henrissat B. Detection of secondary structure elements in proteins by hydrophobic cluster analysis. Protein Eng. 5:1992;629-635.
56. Yamamoto K., Moos C. The C-proteins of rabbit red, white and cardiac muscles. J. Biol. Chem. 258:1983;8395-8401.
57. Yang Q., Sanbe A., Osinska H., Hewett T. E., Klevitsky R., Robbins J. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J. Clin. Invest. 102:1998;1292-1300.